The Foresight CLARITY test offers greater prognostic accuracy than PET/CT scans in large B-cell lymphoma by detecting ctDNA-MRD negativity, indicating better patient outcomes. ctDNA-MRD testing showed ...
As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about the role of PSMA-PET Imaging versus PSA. Prostate specific antigen (PSA) is a ...
Researchers in Denmark conducted a prospective single-centre study including 160 patients with newly diagnosed high-risk prostate cancer between 2021 and 2024. All the participants first underwent an ...
A small veterinary laboratory in California, VDI Labs, is helping more animals survive through early cancer detection – their new biomarker test will aid veterinarians and dog owners in the quest to ...
To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...
AIIMS has secured two high-end machines, including a high energy linear accelerator (HELA) with 3D imaging and positron ...
A combined PSMA-PET/MRI scanner better detected clinically significant prostate cancer in men on active surveillance. The addition of piflufolastat F18 (18 F-DCFPyL) prostate-specific membrane antigen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results